B Heppy
Avsnitt

The Cost of Survival: Navigating Hepatitis B Treatment in America

Dela

In this episode, Bright and Anousha chat with Carl Schmid, Executive Director of the HIV+Hepatitis Policy Institute, about the financial challenges people living with hepatitis B face in the U.S., including high medication costs, insurance barriers, and the ongoing struggle to access affordable, life-saving treatment.

Note: 

Carl also shared an important update that at least one widely used hepatitis B medication is now available through Trump Rx for about $20 per month, offering a potentially more affordable option for some patients.

Support the show

Our website: www.hepb.org
Support B Heppy!
Social Media: Instagram - Twitter - Facebook

Podden och tillhörande omslagsbild på den här sidan tillhör Hepatitis B Foundation. Innehållet i podden är skapat av Hepatitis B Foundation och inte av, eller tillsammans med, Poddtoppen.